AstraZeneca R&D employs over 12,000 people at research facilities in the UK, the US, Sweden, France, Canada, India, China and Japan, complemented by a worldwide clinical development capability.
We continue to invest in our facilities to further improve our capability in leading edge science.
Not signed in
Page tools
Share price
- London
-
26.95 GBP - New York
-
44.82 USD - Stockholm
-
310.10 SEK
At 21-Nov-2009 02:34 GMT
Detailed share priceIntroduction to AstraZeneca
Our responsibility
We continue to communicate openly on a range of issues, including:
